AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 12827099 — intervention group
Group type: COMPARATOR
Intervention: Routine Care
Number of subjects: 35
Study 10636511 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene 30, 60, or 150 mg per day
Number of subjects: 969
Study 10636511 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 969
Study 8833216 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal salmon calcitonin (SCT) 200 IU
Number of subjects: 62
Study 8833216 — intervention group
Group type: COMPARATOR
Intervention: Nasal placebo
Number of subjects: 62
Study 1568586 — intervention group
Group type: EXPERIMENTAL
Intervention: Sclerotherapy plus propranolol (group 2)
Number of subjects: 75
Study 1568586 — intervention group
Group type: COMPARATOR
Intervention: Sclerotherapy alone (group 1)
Number of subjects: 75
Study 3926567 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion (CSII)
Number of subjects: 70
Study 3926567 — intervention group
Group type: COMPARATOR
Intervention: Conventional insulin treatment (CIT)
Number of subjects: 70
Study 30780194 — intervention group
Group type: COMPARATOR
Intervention: Half-dose clarithromycin group (esomeprazole 20 mg bid, amoxicillin 1 g bid, clarithromycin 250 mg bid, bismuth potassium citrate 0.6 g bid) for 14 days
Number of subjects: 210
Study 30780194 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard-dose clarithromycin group (esomeprazole 20 mg bid, amoxicillin 1 g bid, clarithromycin 500 mg bid, bismuth potassium citrate 0.6 g bid) for 14 days
Number of subjects: 210
Study 29226355 — intervention group
Group type: EXPERIMENTAL
Intervention: Low working memory in Grade 1
Number of subjects: 1802
Study 29226355 — intervention group
Group type: COMPARATOR
Intervention: Grade 1 low working memory
Number of subjects: 1802
Study 29226355 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard scores for verbal, visuospatial, and overall working memory
Number of subjects: 1802
Study 26599039 — intervention group
Group type: EXPERIMENTAL
Intervention: Red wine polyphenols
Number of subjects: 10
Study 26599039 — intervention group
Group type: COMPARATOR
Intervention: De-alcoholized red wine
Number of subjects: 10
Study 25070960 — intervention group
Group type: EXPERIMENTAL
Intervention: Terutroban
Number of subjects: 1141
Study 25070960 — intervention group
Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 1141
Study 25070960 — intervention group
Group type: COMPARATOR
Intervention: Comparison of Terutroban and Aspirin
Number of subjects: 1141
Study 23131115 — intervention group
Group type: EXPERIMENTAL
Intervention: M5 EBM (one-semester EBM course)
Number of subjects: 289
Study 23131115 — intervention group
Group type: EXPERIMENTAL
Intervention: M6 (exposed to EBM instruction during the previous year)
Number of subjects: 289
Study 23131115 — intervention group
Group type: COMPARATOR
Intervention: M5 non-EBM (control group)
Number of subjects: 289
Study 23131115 — intervention group
Group type: COMPARATOR
Intervention: M4 (not yet exposed)
Number of subjects: 289
Study 20946740 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol-specific support (measured by network drinking and opposition to patient drinking)
Number of subjects: 1373
Study 20946740 — intervention group
Group type: EXPERIMENTAL
Intervention: Other measures of network support
Number of subjects: 1373
Study 18035006 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol-remifentanil group (n=25)
Number of subjects: 50
Study 18035006 — intervention group
Group type: COMPARATOR
Intervention: Etomidate-remifentanil group (n=25)
Number of subjects: 50
Study 16217243 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E
Number of subjects: 121
Study 16217243 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium
Number of subjects: 121
Study 16217243 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E and Selenium (combination)
Number of subjects: 121
Study 16217243 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 121
Study 12048320 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance-trained men
Number of subjects: 20
Study 9456279 — intervention group
Group type: EXPERIMENTAL
Intervention: sotalol, 120 mg daily (n = 93)
Number of subjects: 191
Study 9456279 — intervention group
Group type: COMPARATOR
Intervention: metoprolol, 75 mg daily (n = 98)
Number of subjects: 191
Study 9456279 — intervention group
Group type: EXPERIMENTAL
Intervention: sotalol
Number of subjects: 191
Study 7615283 — intervention group
Group type: EXPERIMENTAL
Intervention: Real time, electromagnetic imaging system (imager view)
Number of subjects: 55
Study 7615283 — intervention group
Group type: COMPARATOR
Intervention: Standard colonoscopy (without imager view)
Number of subjects: 55
Study 2240092 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous closure (201 patients)
Number of subjects: 402
Study 2240092 — intervention group
Group type: COMPARATOR
Intervention: Interrupted en bloc (201 patients)
Number of subjects: 402
Study 708547 — intervention group
Group type: EXPERIMENTAL
Intervention: General anaesthesia
Number of subjects: 32
Study 708547 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional anaesthesia (lumbar extradural blockade)
Number of subjects: 32
Study 31498125 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive training
Number of subjects: 146
Study 31498125 — intervention group
Group type: COMPARATOR
Intervention: Physical exercise training
Number of subjects: 146
Study 31498125 — intervention group
Group type: COMPARATOR
Intervention: Mindfulness practice
Number of subjects: 146
Study 31498125 — intervention group
Group type: COMPARATOR
Intervention: Active control group
Number of subjects: 146
Study 27258204 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral acetylsalicylic acid 100 mg per day after dinner
Number of subjects: 96
Study 27258204 — intervention group
Group type: COMPARATOR
Intervention: Control group (PICC maintain technique only)
Number of subjects: 96
Study 26514213 — intervention group
Group type: COMPARATOR
Intervention: Waxy maize starch (WMS)
Number of subjects: 0
Study 26514213 — intervention group
Group type: EXPERIMENTAL
Intervention: Waxy maize starch and whey protein (WMS+WP)
Number of subjects: 0
Study 26514213 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistant starch (RS)
Number of subjects: 0
Study 26514213 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistant starch and whey protein (RS+WP)
Number of subjects: 0
Study 22546942 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP + PT (single session of adjunctive phototherapy)
Number of subjects: 27
Study 22546942 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP + rPT (repeated sessions of adjunctive phototherapy)
Number of subjects: 27
Study 22546942 — intervention group
Group type: COMPARATOR
Intervention: SRP (control group)
Number of subjects: 27
Study 20721930 — intervention group
Group type: EXPERIMENTAL
Intervention: FRAX calculator with baseline BMD
Number of subjects: 1422
Study 20721930 — intervention group
Group type: EXPERIMENTAL
Intervention: FRAX calculator without baseline BMD
Number of subjects: 1422
Study 20721930 — intervention group
Group type: EXPERIMENTAL
Intervention: Garvan calculator
Number of subjects: 1422
Study 20721930 — intervention group
Group type: COMPARATOR
Intervention: Models using only age and BMD
Number of subjects: 1422
Study 18985633 — intervention group
Group type: EXPERIMENTAL
Intervention: End-to-end anastomosis
Number of subjects: 77
Study 18985633 — intervention group
Group type: COMPARATOR
Intervention: End-to-side anastomosis
Number of subjects: 77
Study 17679249 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine transdermal patch
Number of subjects: 305
Study 17679249 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 305
Study 15247755 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% testosterone gel (T-gel)
Number of subjects: 75
Study 15247755 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 75
Study 11772480 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-report (SR) plus breath carbon monoxide (CO) monitoring
Number of subjects: 200
Study 11772480 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-report (SR) plus urine cotinine (COT) analysis
Number of subjects: 200
Study 11772480 — intervention group
Group type: COMPARATOR
Intervention: Nonsmoking self-reports
Number of subjects: 200
Study 9439492 — intervention group
Group type: EXPERIMENTAL
Intervention: sICAM‐1 concentrations in the highest quartile (> 260 ng/mL)
Number of subjects: 14916
Study 9439492 — intervention group
Group type: EXPERIMENTAL
Intervention: sICAM‐1 concentrations in the highest quartile
Number of subjects: 14916
Study 9439492 — intervention group
Group type: COMPARATOR
Intervention: sICAM‐1 concentrations
Number of subjects: 14916
Study 8120405 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 microgram rhu IL-1R
Number of subjects: 15
Study 8120405 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 micrograms rhu IL-1R
Number of subjects: 15
Study 8120405 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 micrograms rhu IL-1R
Number of subjects: 15
Study 8120405 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 micrograms rhu IL-1R
Number of subjects: 15
Study 8120405 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 micrograms rhu IL-1R
Number of subjects: 15
Study 8120405 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 2568824 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuroleptic treatment for three to four months
Number of subjects: 62
Study 2568824 — intervention group
Group type: COMPARATOR
Intervention: Placebo baseline
Number of subjects: 62
Study 2568824 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuroleptic treatment
Number of subjects: 62
Study 2568824 — intervention group
Group type: COMPARATOR
Intervention: Drug-free baseline
Number of subjects: 62
Study 2568824 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive syndrome
Number of subjects: 62
Study 357309 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial trials on a limited number of patients for specific disease control or prophylaxis
Number of subjects: 0
Study 357309 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled clinical studies of antirheumatic and antianginal drugs
Number of subjects: 0
Study 28957795 — intervention group
Group type: EXPERIMENTAL
Intervention: Rasahara and Yoga
Number of subjects: 157
Study 28957795 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 157
Study 28957795 — intervention group
Group type: COMPARATOR
Intervention: No intervention (Control)
Number of subjects: 157
Study 27267551 — intervention group
Group type: EXPERIMENTAL
Intervention: Voluntary exercise program (EX-group)
Number of subjects: 125
Study 27267551 — intervention group
Group type: COMPARATOR
Intervention: No exercise (NoEX-group)
Number of subjects: 125
Study 27267551 — intervention group
Group type: EXPERIMENTAL
Intervention: EX-group
Number of subjects: 125
Study 25146491 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus HN001
Number of subjects: 331
Study 25146491 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifidobacterium animalis subsp lactis HN019
Number of subjects: 331
Study 25146491 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 331
Study 22487079 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensor-augmented pump system
Number of subjects: 131
Study 22487079 — intervention group
Group type: COMPARATOR
Intervention: Conventional insulin pump therapy
Number of subjects: 131
Study 22487079 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequent sensor use
Number of subjects: 131
Study 22487079 — intervention group
Group type: EXPERIMENTAL
Intervention: Irregular or no sensor use
Number of subjects: 131
Study 22487079 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily insulin requirements
Number of subjects: 131
Study 20099953 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnosis
Number of subjects: 200
Study 20099953 — intervention group
Group type: COMPARATOR
Intervention: Attention Control
Number of subjects: 200
Study 18578564 — intervention group
Group type: EXPERIMENTAL
Intervention: 23-minute video intervention depicting couples overcoming barriers to safer sexual behaviors
Number of subjects: 38635
Study 18578564 — intervention group
Group type: COMPARATOR
Intervention: Standard waiting room environment (control)
Number of subjects: 38635
Study 18578564 — intervention group
Group type: EXPERIMENTAL
Intervention: 23-minute video intervention
Number of subjects: 38635
Study 15892085 — intervention group
Group type: EXPERIMENTAL
Intervention: Adacolumn® treatment
Number of subjects: 6
Study 15892085 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 6
Study 15892085 — intervention group
Group type: EXPERIMENTAL
Intervention: G-1 beads (in vitro)
Number of subjects: 6
Study 12538276 — intervention group
Group type: EXPERIMENTAL
Intervention: Arch-first technique (group A)
Number of subjects: 19
Study 12538276 — intervention group
Group type: COMPARATOR
Intervention: Conventional technique (group B)
Number of subjects: 19
Study 12538276 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 19
Study 10862528 — intervention group
Group type: COMPARATOR
Intervention: Walking (low intensity)
Number of subjects: 64
Study 10862528 — intervention group
Group type: EXPERIMENTAL
Intervention: Weights (high intensity strength training)
Number of subjects: 64
Study 10862528 — intervention group
Group type: EXPERIMENTAL
Intervention: WeightsHRT (high intensity strength training with HRT)
Number of subjects: 64
Study 10862528 — intervention group
Group type: COMPARATOR
Intervention: WalkingHRT (low intensity walking with HRT)
Number of subjects: 64
Study 8665629 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.1%
Number of subjects: 44
Study 8665629 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.2%
Number of subjects: 44
Study 8665629 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.3%
Number of subjects: 44
Study 8665629 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 44
Study 1923397 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily chlorhexidine rinsing (0.12% solution)
Number of subjects: 42
Study 1923397 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly chlorhexidine rinsing (0.12% solution)
Number of subjects: 42
Study 1923397 — intervention group
Group type: COMPARATOR
Intervention: Control (no rinsing)
Number of subjects: 42
Study 6135029 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporin A (CyA)
Number of subjects: 0
Study 6135029 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduction of CyA dose
Number of subjects: 0
Study 6135029 — intervention group
Group type: EXPERIMENTAL
Intervention: Demonstration of CyA in cytological specimens
Number of subjects: 0
Study 31638006 — intervention group
Group type: EXPERIMENTAL
Intervention: Formative Objective Structured Clinical Examination (OSCE) in pediatric module with feedback
Number of subjects: 119
Study 31638006 — intervention group
Group type: COMPARATOR
Intervention: Standard pediatric module (Control)
Number of subjects: 119
Study 29023670 — intervention group
Group type: EXPERIMENTAL
Intervention: Tuning Peg algorithm
Number of subjects: 0
Study 26995367 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhythm control strategy
Number of subjects: 9542
Study 26995367 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin treatment
Number of subjects: 9542
Study 26995367 — intervention group
Group type: COMPARATOR
Intervention: Long-term outcomes associated with AF
Number of subjects: 9542
Study 26995367 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of life (QoL)
Number of subjects: 9542
Study 26247960 — intervention group
Group type: COMPARATOR
Intervention: EPA + DHA supplementation (0-4 portions of oily fish/week, equivalent to 3.27 g EPA+DHA per portion)
Number of subjects: 0
Study 26247960 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 22658422 — intervention group
Group type: EXPERIMENTAL
Intervention: Dobutamine
Number of subjects: 70
Study 22658422 — intervention group
Group type: COMPARATOR
Intervention: Exercise echocardiography
Number of subjects: 70
Study 20461803 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropinirole prolonged-release (mean dose 10 mg/d)
Number of subjects: 208
Study 20461803 — intervention group
Group type: COMPARATOR
Intervention: Levodopa (mean additional dose 284 mg/d)
Number of subjects: 208
Study 20461803 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropinirole prolonged-release
Number of subjects: 208
Study 20461803 — intervention group
Group type: COMPARATOR
Intervention: Levodopa
Number of subjects: 208
Study 20461803 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropinirole prolonged-release and Levodopa
Number of subjects: 208
Study 18815665 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone (AMD) treatment
Number of subjects: 96
Study 18815665 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone (AMD) treatment for more than 24 months
Number of subjects: 96
Study 16249738 — intervention group
Group type: EXPERIMENTAL
Intervention: CsA‐ME (Neoral) with C2 monitoring
Number of subjects: 123
Study 12152001 — intervention group
Group type: COMPARATOR
Intervention: Intracoronary infusion of rhVEGF(165) at a dose rate of 17 or 50 ng/kg/min for 20 minutes, followed by three 4-hour intravenous infusions on days 3, 6, and 9
Number of subjects: 0
Study 12152001 — intervention group
Group type: COMPARATOR
Intervention: Intravenous infusion of rhVEGF(165)
Number of subjects: 0
Study 10548998 — intervention group
Group type: EXPERIMENTAL
Intervention: Berliner Lebensqualitätsprofil (BELP)
Number of subjects: 36
Study 10548998 — intervention group
Group type: EXPERIMENTAL
Intervention: Short form of the Berliner Lebensqualitätprofil (BELP-KF)
Number of subjects: 36
Study 10548998 — intervention group
Group type: EXPERIMENTAL
Intervention: Satisfaction with psychopharmacological treatment
Number of subjects: 36
Study 10548998 — intervention group
Group type: EXPERIMENTAL
Intervention: Satisfaction with sexual life
Number of subjects: 36
Study 8786016 — intervention group
Group type: EXPERIMENTAL
Intervention: ALA 1200 mg
Number of subjects: 328
Study 8786016 — intervention group
Group type: EXPERIMENTAL
Intervention: ALA 600 mg
Number of subjects: 328
Study 8786016 — intervention group
Group type: EXPERIMENTAL
Intervention: ALA 100 mg
Number of subjects: 328
Study 8786016 — intervention group
Group type: COMPARATOR
Intervention: PLAC
Number of subjects: 328
Study 8786016 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events
Number of subjects: 328
Study 2178667 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatinum alone
Number of subjects: 200
Study 2178667 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate alone
Number of subjects: 200
Study 2178667 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatinum + 5-FU
Number of subjects: 200
Study 2178667 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatinum + methotrexate
Number of subjects: 200
Study 2178667 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatinum arms
Number of subjects: 200
Study 2178667 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination regimens (cisplatinum + methotrexate or cisplatinum + 5-FU)
Number of subjects: 200
Study 7044467 — intervention group
Group type: EXPERIMENTAL
Intervention: lipid-lowering therapy by diet and drugs
Number of subjects: 24
Study 7044467 — intervention group
Group type: COMPARATOR
Intervention: usual-care
Number of subjects: 24
Study 30562710 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab
Number of subjects: 0
Study 30562710 — intervention group
Group type: COMPARATOR
Intervention: Docetaxel
Number of subjects: 0
Study 28434467 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal electroacupuncture for 6 weeks
Number of subjects: 440
Study 28434467 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular acupuncture
Number of subjects: 440
Study 28434467 — intervention group
Group type: COMPARATOR
Intervention: Sham groups (control)
Number of subjects: 440
Study 25224684 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonic nebulization (Pulmicort, 2 × 1 mg/4 mL)
Number of subjects: 30
Study 25224684 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral route (Medrol, 32 mg/8 days ‐16 mg/4 days‐8 mg/4 days)
Number of subjects: 30
Study 25224684 — intervention group
Group type: COMPARATOR
Intervention: Nasal spray (Rhinocort, 2 × 2 × 64 µg/nostril)
Number of subjects: 30
Study 25224684 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (sonic nebulization, oral, nasal spray)
Number of subjects: 30
Study 24158342 — intervention group
Group type: EXPERIMENTAL
Intervention: Implant overdentures (IODs)
Number of subjects: 34
Study 24158342 — intervention group
Group type: COMPARATOR
Intervention: Conventional relines
Number of subjects: 34
Study 21659672 — intervention group
Group type: EXPERIMENTAL
Intervention: Performance‐contingent monetary incentive
Number of subjects: 45
Study 21659672 — intervention group
Group type: EXPERIMENTAL
Intervention: Video camera placebo
Number of subjects: 45
Study 21659672 — intervention group
Group type: EXPERIMENTAL
Intervention: Video camera self‐presentation
Number of subjects: 45
Study 21659672 — intervention group
Group type: EXPERIMENTAL
Intervention: Audience
Number of subjects: 45
Study 21659672 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined pressure
Number of subjects: 45
Study 21659672 — intervention group
Group type: COMPARATOR
Intervention: Motivational pressure treatments
Number of subjects: 45
Study 19298728 — intervention group
Group type: EXPERIMENTAL
Intervention: Microsurgical testicular sperm extraction (microTESE)
Number of subjects: 138
Study 19298728 — intervention group
Group type: COMPARATOR
Intervention: Conventional TESE
Number of subjects: 138
Study 19298728 — intervention group
Group type: EXPERIMENTAL
Intervention: FSH concentration > or = 3 x maximum value of normal range (N)
Number of subjects: 138
Study 19298728 — intervention group
Group type: EXPERIMENTAL
Intervention: 2N < or = FSH < 3N
Number of subjects: 138
Study 19298728 — intervention group
Group type: EXPERIMENTAL
Intervention: N < FSH < 2N
Number of subjects: 138
Study 19298728 — intervention group
Group type: EXPERIMENTAL
Intervention: FSH = N
Number of subjects: 138
Study 19298728 — intervention group
Group type: EXPERIMENTAL
Intervention: Volume (V) > or = 12 ml
Number of subjects: 138
Study 19298728 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 ml < or = V < 12 ml
Number of subjects: 138
Study 19298728 — intervention group
Group type: EXPERIMENTAL
Intervention: V < 8 ml
Number of subjects: 138
Study 20859313 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical medial branch blocks with bupivacaine only (Group I)
Number of subjects: 120